Contacter le RP

Pour utiliser cette fonctionnalité, vous devez bénéficier d'un compte Babbler.

arrow_back

Babbler permet aux journalistes et communicants de collaborer plus simplement.

En vous connectant, vous pourrez accéder gratuitement aux espaces presse des centaines d'entreprises de vos secteurs qui sont sur Babbler, entrer en contact direct avec leurs équipes RP mais aussi y partager vos prochains sujets !

Leurs espaces presse sont sur Babbler :

Vous êtes à 1 clic de l'inscription !

Précédent

Content de vous revoir !

Communiqué de presse

Plasminogen Activator Inhibitor Market Restraint, Drivers, Regional Analysis
timer minutes de lecture minute de lecture

Copier le lien
The study aims to measure PAI-1 and tissue plasminogen activator inhibitor levels in the plasma after drug treatment.

Cliquez sur l'image pour obtenir le format original

Plasminogen activator inhibitors also known as Serpin E1 is a protein present in the body whose elevated levels are responsible for thrombosis and atherosclerosis. (Plasminogen Activator Inhibitor Type 1 (PAI-1) is mainly secreted by the endothelium (cells lining blood vessels), and adipose tissues whereas Plasminogen Activator Inhibitor Type 2 (PAI-2) is secreted by the placenta and only present in significant amounts during pregnancy. PAI-1 plays an important role in aging and is secreted in senescent cells. Complete plasminogen activator inhibitor 1 deficiency (complete PAI-1 deficiency) is a disorder that causes abnormal bleeding.

Plasminogen Activator Inhibitor Market – Driver

Increasing number of pipeline drugs for treating wounds and thrombosis can propel the growth of plasminogen activator inhibitor market. For instance, Denver Health and Hospital Authority is undergoing clinical phase II study for treating thromboembolism and wounds by aspirin and rosuvastatin. The study aims to measure PAI-1 and tissue plasminogen activator inhibitor levels in the plasma after drug treatment. The study started in February 2017 and is estimated to complete in December 2021.

Plasminogen Activator Inhibitor Market – Restraint

Increasing product recall due to variations in the PAI kits is responsible for uneven results which is affecting the growth of plasminogen activator inhibitor market. For instance, in July 2016, U.S. Food and Drug Administration (USFDA) recalled IMUBIND Plasma PAI-1 Enzyme Linked Immunosorbant Assay (ELISA) kits manufactured by American Diagnostica, Inc. The recall was initiated due to unacceptable microwell to microwell variation in the section of the ELISA plates that is typically used for the calibrators. This product affected the reproducibility of the results which can restrain the market.

Download the PDF brochure:

https://www.coherentmarketinsights.com/insight/request-pdf/2288

Plasminogen Activator Inhibitor Market – Regional Analysis

On the basis of region, the global plasminogen activator inhibitor market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa.

North America region is estimated to hold prominent position in plasminogen activator inhibitor market due to increased involvement of government initiatives for creating awareness of this rare disease. For instance, in U.S. two organizations, Hemophilia Federation of America (HFA), and National Hemophilia Foundation are working for creating awareness for this genetic disorder. Furthermore, Affected members of the disease are from the Old Order Amish community of eastern and southern Indiana, America developed trauma, extensive sub periosteal bleeding after minor jaw trauma, and epidural hematoma (in an infant) after a head injury according to Nation Center for Biotechnology Information (NCBI) August 2017.

Africa region is also likely notice wide growth in the global plasminogen activator inhibitor market owing to rise in research activity for plasminogen activator inhibitors. For instance, in 2017, World Health Organization (WHO) of Arica completed study on the relation of PAI in the pregnant women with preeclampsia for disease severity. They concluded Plasma levels of PAI-1 are increased early in pregnancies complicated by preeclampsia.

Click To Reading More On Plasminogen Activator Inhibitor Market

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr.Shah

Coherent Market Insights

1001 4th Ave,

#3200

Seattle, WA 98154

Tel: +1-206-701-6702

Email:sales@coherentmarketinsights.com

Visit our news Website: https://www.coherentwire.com

  • Fitness
  • Health & Medicine
  • Medicine
  • Men's Health
  • + 2
  • Sports Medicine
  • Women's Health

Autres actualités de la marque

inscrit avec succès

Félicitations, vous êtes inscrit sur BABBLER !

Pour découvrir dès maintenant toutes les actualités qui vous attendent sur Babbler, consultez votre newsfeed !

Vos domaines ont été préselectionnés. Vous pouvez les compléter en cliquant ici

  • Fitness
  • Health & Medicine
  • Medicine